Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Cash Flow-to-Debt Ratio
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A cash flow-to-debt ratio. Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥15.57 Million could theoretically repay 0% of its total liabilities (CN¥373.70 Million) in one year. Check Wuhan Easy Diagnosis Biomedicine Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
Cash flow-to-debt ratio of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. Historical debt coverage capacity for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A across 15 annual periods. Check 002932 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Cash Flow-to-Debt Ratio by Year (2011–2025)
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A. For the full cash flow conversion analysis, see how efficiently does Wuhan Easy Diagnosis Biomedicine Co Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.22x | CN¥-70.05 Million | CN¥324.56 Million | ▼ -45.8% |
| 2024 | -0.15x | CN¥-85.05 Million | CN¥574.40 Million | ▼ -141.3% |
| 2023 | 0.36x | CN¥392.50 Million | CN¥1.09 Billion | ▼ -78.4% |
| 2022 | 1.66x | CN¥4.01 Billion | CN¥2.42 Billion | ▼ -16.5% |
| 2021 | 1.99x | CN¥1.13 Billion | CN¥567.02 Million | ▲ +72.3% |
| 2020 | 1.15x | CN¥359.68 Million | CN¥311.77 Million | ▲ +17.0% |
| 2019 | 0.99x | CN¥22.49 Million | CN¥22.80 Million | ▼ -54.9% |
| 2018 | 2.19x | CN¥53.67 Million | CN¥24.55 Million | ▼ -36.0% |
| 2017 | 3.42x | CN¥46.50 Million | CN¥13.60 Million | ▲ +28.1% |
| 2016 | 2.67x | CN¥58.86 Million | CN¥22.07 Million | ▲ +10.0% |
| 2015 | 2.42x | CN¥45.02 Million | CN¥18.57 Million | ▲ +68.1% |
| 2014 | 1.44x | CN¥16.47 Million | CN¥11.42 Million | ▲ +133.5% |
| 2013 | 0.62x | CN¥6.30 Million | CN¥10.19 Million | ▲ +93.4% |
| 2012 | 0.32x | CN¥1.03 Million | CN¥3.23 Million | ▲ +228.0% |
| 2011 | -0.25x | CN¥-482.90K | CN¥1.94 Million | — |